CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleRevenue is $3.2B, above the global median of $548.88M
- PositionGross margin is 7%, lower than 95% of its Pharmaceutical Retailers peers (median 25.6%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.05%Below 5Y avg (3.26%)
Annual Rate
CNY 0.35Paid annual
Payout Ratio
50.7%Sustainable
Payback Period
30.7 yr
Last Ex-Dividend
Jul 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.46BCNY665.46M · vs all stocks (USD)
Trailing P/E
16.09xvs Pharmaceutical Retailers peers
Revenue (TTM)
21.43BCNY3.20B · vs all stocks (USD)
Profit Margin
1.26%vs Pharmaceutical Retailers peers
Beta
0.0010xvs all stocks
52-Week Change
41.08%vs all stocks
Market Capitalization
4.46BCNY665.46M · vs all stocks (USD)
Enterprise Value
8.96BCNY1.34B · vs all stocks (USD)
Trailing P/E
16.09xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
0.2012xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
1.30xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.4180xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
14.24xvs Pharmaceutical Retailers peers
Gross Margin
6.97%vs Pharmaceutical Retailers peers
Profit Margin
1.26%vs Pharmaceutical Retailers peers
Operating Margin
2.66%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
2.66%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
8.12%vs Pharmaceutical Retailers peers
Revenue (TTM)
21.43BCNY3.20B · vs all stocks (USD)
Revenue per Share (TTM)
54.92CNYUpdated Sep 21, 2026Quarterly Revenue Growth
0.10%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
1.48BCNY221.43M · vs all stocks (USD)
EBITDA (TTM)
576.38MCNY86.07M · vs all stocks (USD)
Net Income (TTM)
269.36MCNY40.22M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-9.80%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
376.57MCNY56.23M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
33.75MCNY5.04M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3500CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
3.05%vs all stocks
5-Year Average Dividend Yield
3.26%vs all stocks
Payout Ratio
50.72%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
17.09MCNYFY2025 · Dec 31, 2025Revenue
21.25BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
19.74BCNYFY2025 · Dec 31, 2025Gross Profit
1.50BCNYFY2025 · Dec 31, 2025Operating Income
597.30MCNY89.19M · vs all stocks (USD)
Pre-tax Income
376.23MCNYFY2025 · Dec 31, 2025Income Tax Expense
97.25MCNYFY2025 · Dec 31, 2025Net Income
278.98MCNYFY2025 · Dec 31, 2025EBIT
554.58MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
721.13MCNYFY2025 · Dec 31, 2025Research & Development
6.52MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
136.34MCNYFY2025 · Dec 31, 2025Other Operating Expenses
54.31MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.66MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
178.36MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7200CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
390.12MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
390.12MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
278.98MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.90MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-155.24MCNYFY2025 · Dec 31, 2025Free Cash Flow
-388.14MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
345.20MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
278.98MCNYFY2025 · Dec 31, 2025Other Non-cash Items
189.44MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-444.37MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-179.29MCNYFY2025 · Dec 31, 2025Capital Expenditures
-232.90MCNYFY2025 · Dec 31, 2025Purchase of Investments
-10.09MCNYFY2025 · Dec 31, 2025Other Investing Activity
-580.07KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-243.58MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
9.50BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-9.55BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-313.96MCNYFY2025 · Dec 31, 2025Other Financing Charges
-76.69MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-439.92MCNYFY2025 · Dec 31, 2025Shares Outstanding
388.52MSharesUpdated Sep 21, 2026Float Shares
232.28MSharesUpdated Sep 21, 2026% Held by Insiders
42.44%vs all stocks
% Held by Institutions
1.00%vs all stocks
Total Cash (MRQ)
648.67MCNY96.87M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.67CNYUpdated Sep 21, 2026Total Debt (MRQ)
5.28BCNY788.40M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.59xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.10xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
8.53CNYUpdated Sep 21, 2026Total Assets
13.40BCNY2.00B · vs all stocks (USD)
Total Current Assets
10.46BCNYFY2025 · Dec 31, 2025Total Liabilities
10.07BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.94BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
489.30MCNYFY2025 · Dec 31, 2025Total Current Liabilities
9.58BCNYFY2025 · Dec 31, 2025Cash
333.66MCNYFY2025 · Dec 31, 2025Cash Equivalents
283.30MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
616.96MCNYFY2025 · Dec 31, 2025Accounts Receivable
6.36BCNYFY2025 · Dec 31, 2025Inventory
3.04BCNYFY2025 · Dec 31, 2025Accounts Payable
4.71BCNYFY2025 · Dec 31, 2025Short-term Debt
4.48BCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.75MCNYFY2025 · Dec 31, 2025Long-term Debt
408.87MCNYFY2025 · Dec 31, 2025Common Stock (Book)
388.52MCNYFY2025 · Dec 31, 2025Retained Earnings
2.10BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.32BCNY496.38M · vs all stocks (USD)
52-Week Low
7.90CNYUpdated Sep 21, 202652-Week High
28.29CNYUpdated Sep 21, 202652-Week Change
41.08%vs all stocks
Beta
0.0010xvs all stocks
50-Day MA
10.86CNYUpdated Sep 21, 2026200-Day MA
13.97CNYUpdated Sep 21, 2026Avg 10-Day Volume
15.11MSharesUpdated Sep 21, 2026Avg 30-Day Volume
15.82MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.6900CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 7%, lower than 95% of its Pharmaceutical Retailers peers (median 25.6%)Significant
Gross margin: 0.07Industry median: 0.26Industry P5: 0.07Peers compared: 21.00
Financial Health
Altman Z-Score 2.28: grey zoneSignificant
Altman Z-Score: 2.28
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $3.2B, above the global median of $548.88MNotable
Revenue (USD): 3,200,025,628.078Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
Arata Corporation
Tier 1FlowUnit ReplicationInterfaceProduction
Petco Health and Wellness Company, Inc.
Tier 1FlowUnit ReplicationInterfaceRisk
Wangli Security & Surveillance Co., Ltd.
Tier 1FlowUnit ReplicationProductionRule
Natural Grocers by Vitamin Cottage, Inc.
Tier 1FlowUnit ReplicationInterfaceAttention
Zhongbai Holdings Group Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Axial Retailing Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Cass Information Systems, Inc.
Tier 1FlowUnit ReplicationProductionSenseMaking
União Pet Participações S.A.
Tier 1FlowUnit ReplicationInterfaceProduction
Halows Co. Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Shanghai Laiyifen Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Jiangsu Zhenjiang New Energy Co. Ltd.
1 interpretationElevated Leverage on Three Denominators
Electra Ltd.
1 interpretationElevated Leverage on Three Denominators
Federal Agricultural Mortgage Corporation
1 interpretationElevated Leverage on Three Denominators